COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01695941
Brief Title: Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma

First Submitted : September 26, 2012
First Submitted that Met QC Criteria : September 26, 2012
First Posted : September 28, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : May 9, 2020
Last Update Posted : May 12, 2020